Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024
06:17am, Saturday, 25'th Jan 2025
The Dow Jones Industrial Average (DJIA) is a group of 30 U.S. industry leaders. It's often looked at as a proxy for the market, since its components' performance is indicative of what's happening in t
Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing
07:01pm, Thursday, 23'rd Jan 2025
Amgen (AMGN) reachead $277.88 at the closing of the latest trading day, reflecting a +1.62% change compared to its last close.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Thursday, 23'rd Jan 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?
05:34am, Tuesday, 21'st Jan 2025
2024 was an excellent year for the major stock market indexes. But the Dow Jones Industrial Average (^DJI 0.78%) had just a 12.9% return, compared to 23.3% for the S&P 500 (^GSPC 1.00%) and 28.6% for
Amgen's Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer
10:21am, Monday, 20'th Jan 2025
The FDA approves Amgen's Lumakras in combination with Vectibix for treating previously treated adults with KRAS G12C-mutated metastatic colorectal cancer.
Amgen (AMGN) Rises Yet Lags Behind Market: Some Facts Worth Knowing
06:55pm, Friday, 17'th Jan 2025
In the latest trading session, Amgen (AMGN) closed at $272.11, marking a +0.99% move from the previous day.
Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif. , Jan. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today anno
US FDA approves Amgen's colorectal cancer therapy
07:00pm, Thursday, 16'th Jan 2025
The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation.
2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows
08:00am, Thursday, 16'th Jan 2025
Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this idea is that investing in the right stock at the right time -- and holding onto it for a while -
Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know
07:01pm, Tuesday, 14'th Jan 2025
In the most recent trading session, Amgen (AMGN) closed at $267.10, indicating a -1.14% shift from the previous trading day.
Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term
10:50am, Tuesday, 14'th Jan 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 14'th Jan 2025
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.
07:25am, Tuesday, 14'th Jan 2025
A $5,000 investment can go a long way, especially if you're loading up on fairly cheap stocks that may possess a lot of upside in the long run. By investing $5,000, you can ensure that if you pick a g
Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)
08:36pm, Monday, 13'th Jan 2025
Amgen Inc. (NASDAQ:AMGN ) 43rd Annual J.P. Morgan Healthcare Conference 2025 January 13, 2025 6:00 PM ET Company Participants Robert Bradway - Chairman, CEO & President Conference Call Participants Ch
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
06:10pm, Monday, 13'th Jan 2025
This article will provide an in-depth analysis of drugs being developed to combat cancer. Big Pharma is keenly interested in the global cancer therapeutics market, which is expected to exceed $400 bil
